Document:

Amendment No. 2 to Credit Agreement

 Exhibit 10.2 
 EXECUTION VERSION 
 AMENDMENT NO. 2 

TO 

CREDIT AGREEMENT 
 This AMENDMENT No. 2 dated as of August 27, 2012 (this “Amendment”), is entered into among AMERICAN RENAL HOLDINGS INTERMEDIATE COMPANY, LLC, a Delaware limited
liability company (“Holdings”), AMERICAN RENAL HOLDINGS INC., a Delaware corporation (the “Borrower”), the Subsidiary Guarantors party hereto and BANK OF AMERICA, N.A., in its capacity as administrative agent for
the Lenders (as hereinafter defined) (in such capacity, the “Administrative Agent”), and amends the Credit Agreement dated as of May 7, 2010 (as amended to the date hereof and as the same may be further amended, supplemented or
otherwise modified from time to time, the “Credit Agreement”) entered into among Holdings, the Borrower, the institutions from time to time party thereto as Lenders (the “Lenders”), the Administrative Agent, and the
other agents and arrangers party thereto. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Credit Agreement. 
 W I T N E S S E T H: 
 WHEREAS, the Borrower has requested that the
Lenders amend the Credit Agreement to effect the changes described below; 
 NOW, THEREFORE, in
consideration of the premises and for other good and valuable consideration (the receipt and sufficiency of which is hereby acknowledged), the parties hereto hereby agree as follows: 

Section1. Amendments to the Credit Agreement 

 

	 	a)	The definition of “Applicable Rate” in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirety as follows:

 “Applicable Rate” means the applicable percentage per annum set forth below determined by
reference to the Consolidated Leverage Ratio as set forth in the most recent Compliance Certificate received by the Administrative Agent pursuant to Section 6.02(b): 

Applicable Rate 
  

											
	 Pricing Level
	  	 Consolidated
Leverage Ratio
	  	 Eurodollar Rate Loans

(Letter of Credit Fees)
	 	 	 Base Rate Loans
	 
	         1
	  	>4.00:1	  	 	4.25	% 	 	 	3.25	% 
	         2
	  	<4.00:1 but>3.50:l	  	 	3.75	% 	 	 	2.75	% 
	         3
	  	<3.50:1	  	 	3.25	% 	 	 	2.25	% 

 Any increase or decrease in the Applicable Rate resulting from a change in the Consolidated
Leverage Ratio shall become effective as of the first Business Day immediately following the date a Compliance Certificate is delivered pursuant to Section 6.02(b); provided, however, that if a Compliance Certificate is not
delivered when due in accordance with such Section, then, upon the request of the Required Lenders, Pricing Level 1 shall apply, in each case as of the first Business Day after the date on which such Compliance Certificate was required to have been
delivered and in each case shall remain in effect until the date on which such Compliance Certificate is delivered. 
 If, as a
result of any restatement of or other adjustment to the financial statements of the Borrower or for any other reason, the Borrower or the Lenders determine that (i) the Consolidated Leverage Ratio as calculated by the Borrower as of any
applicable date was inaccurate and (ii) a proper calculation of the Consolidated Leverage Ratio would have resulted in higher pricing for such period, the Borrower shall immediately and retroactively be obligated to pay to the Administrative
Agent for the account of the applicable Lenders or the L/C Issuer, as the case may be, promptly on demand by the Administrative Agent (or, after the occurrence of an actual or deemed entry of an order for relief with respect to the Borrower under
the Bankruptcy Code of the United States, automatically and without further action by the Administrative Agent, any Lender or the L/C Issuer), an amount equal to the excess of the amount of interest that should have been paid for such period over
the amount of interest actually paid for such period. This paragraph shall not limit the rights of the Administrative Agent, any Lender or the L/C Issuer, as the case may be, under Section 2.03(c)(iii), 2.03(h) or 2.08(b)
or under Article VIII. The Borrower’s obligations under this paragraph shall survive the termination of the Commitments and the repayment of all other Obligations hereunder. 

 

	 	b)	Schedule 2.01 to the Credit Agreement is hereby amended and restated in its entirety as set forth on Schedule A hereto. 

Section 2. Conditions to Effectiveness 
 This Amendment shall become effective as of the date first written above when, and only when, the Administrative Agent shall have received this Amendment, duly executed by Holdings, the Borrower, the
Administrative Agent and each of the Lenders. The effectiveness of this Amendment is also conditioned upon (i) delivery of each of the documents listed in clauses (a)-(c) below and (ii) the payment of all fees and expenses due and
payable pursuant Section 4 hereof. 
  

	 	a)	Legal Opinion. Receipt by the Administrative Agent of the legal opinion of Simpson, Thacher & Bartlett LLP counsel to the Loan Parties.

  

	 	b)	Corporate Documents. Receipt by the Administrative Agent of the following (or their equivalent), each certified by the secretary or assistant secretary of the
applicable Loan Party to be true and correct and in force and effect in a certificate in a form reasonably satisfactory to the Administrative Agent: 

  
 -2-

 (i) Articles of Incorporation. Copies of the articles of
incorporation or other charter documents of each Loan Party certified to be true and complete as of a recent date by the appropriate Governmental Authority of the state of its organization. 

(ii) Resolutions. Copies of resolutions of the board of directors or comparable managing body of each Loan Party
approving and adopting the Amendment, the transactions contemplated therein and authorizing execution and delivery thereof. 
 (iii) Bylaws. Copies of the bylaws, operating agreement or partnership agreement of each Loan Party (or a certification by the secretary or assistant secretary of the applicable Loan Party that
there have been no changes to such documents as delivered to the Administrative Agent on the Closing Date). 

(iv) Good Standing. Copies, where applicable, of certificates of good standing, existence or the equivalent of
each Loan Party in its state of organization, certified as of a recent date by the appropriate Governmental Authorities of the applicable state of organization. 
  

	 	c)	Officer’s Certificate. Receipt by the Administrative Agent of a certificate, in form and substance reasonably satisfactory to it, of a Responsible Officer
certifying that the representations in Section 3 hereof are true and correct as of the date first written above. 

 Section 3. Representations and Warranties 
 On and as of the
date hereof, the Borrower hereby represents and warrants to the Administrative Agent and each Lender that (x) this Amendment has been duly authorized, executed and delivered by the Borrower and Holdings and constitutes a legal, valid and
binding obligation of the Borrower and Holdings enforceable against the Borrower and Holdings in accordance with its terms, subject to (i) applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar
laws relating to affecting creditors’ rights generally and (ii) general equitable principles (whether considered in a proceeding in equity or at law), (y) the representations and warranties in the Loan Documents are true and correct
in all material respects (except that any representation and warranty that is qualified as to “materiality” or “Material Adverse Effect” shall be true and correct in all respects), except to the extent that such representations
and warranties specifically refer to an earlier date, in which case they shall be true and correct in all material respects (except that any representation and warranty that is qualified as to “materiality” or “Material Adverse
Effect” shall be true and correct in all respects) as of such earlier date and (z) no Default or Event of Default shall have occurred and be continuing. 
 Section 4. Fees and Expenses 
 The Borrower agrees
to reimburse the Administrative Agent for all fees due to it and its Affiliates and also for the reasonable and invoiced out-of-pocket expenses incurred by them in connection with this Amendment, including the reasonable and invoiced fees, charges
and disbursements of Cahill Gordon & Reindel LLP, counsel for the Administrative Agent. 

  
 -3-

 Section 5. Reference to the Effect on the Loan Documents 

Each reference in the Credit Agreement to “this Agreement,” “hereunder,” “hereof,”
“herein,” or words of like import, and each reference in the other Loan Documents to the Credit Agreement (including, without limitation, by means of words like “thereunder,” “thereof” and words of like
import), shall mean and be a reference to the Credit Agreement, as amended hereby, and this Amendment and the Credit Agreement shall be read together and construed as a single instrument. 

Except as expressly amended hereby, all of the terms and provisions of the Credit Agreement and all other Loan Documents are and shall
remain in full force and effect and are hereby ratified and confirmed. 
 The execution, delivery and effectiveness of this
Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of the Lenders, Holdings, the Borrower or the Administrative Agent under any of the Loan Documents, nor constitute a waiver or amendment of
any other provision of any of the Loan Documents or for any purpose except as expressly set forth herein. 
 This Amendment is a
Loan Document. 
 The Borrower has heretofore executed and delivered to the Administrative Agent the Security Agreement. Each
Guarantor has heretofore executed and delivered to the Administrative Agent the Security Agreement and the Guaranty. Each Loan Party hereby consents to this Amendment. Each Loan Party acknowledges and agrees that, notwithstanding the execution and
delivery of this Amendment, the Security Agreement and, to the extent such Loan Party is a party thereto, the Guaranty executed and delivered to the Administrative Agent by such Loan Party remain in full force and effect and the rights and remedies
of the Administrative Agent thereunder and the obligations of such Loan Party thereunder remain in full force and effect and shall not be affected, impaired or discharged hereby. 

Section 6. Execution in Counterparts 
 This Amendment may be executed in any number of counterparts and by different parties in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement. Signature pages may be detached from multiple separate counterparts and attached to a single counterpart so that all signature pages are attached to the same document. Delivery of an executed
counterpart by telecopy or other electronic transmission shall be effective as delivery of a manually executed counterpart of this Amendment. 
 Section 7. Governing Law 
 This Amendment shall be construed in
accordance with and governed by the laws of the State of New York. 

  
 -4-

 Section 8. Section Titles 

The section titles contained in this Amendment are and shall be without substantive meaning or content of any kind whatsoever and are not
a part of the agreement between the parties hereto, except when used to reference a section. Any reference to the number of a clause, sub-clause or subsection of any Loan Document immediately followed by a reference in parenthesis to the title of
the section of such Loan Document containing such clause, sub-clause or subsection is a reference to such clause, sub-clause or subsection and not to the entire section; provided, however, that, in case of direct conflict between the
reference to the title and the reference to the number of such section, the reference to the title shall govern absent manifest error. If any reference to the number of a section (but not to any clause, sub-clause or subsection thereof) of any Loan
Document is followed immediately by a reference in parenthesis to the title of a section of any Loan Document, the title reference shall govern in case of direct conflict absent manifest error. 

Section 9. Notices 
 All communications and notices hereunder shall be given as provided in the Credit Agreement. 
 Section 10. Severability 
 The fact that any term or provision
of this Agreement is held invalid, illegal or unenforceable as to any person in any situation in any jurisdiction shall not affect the validity, enforceability or legality of the remaining terms or provisions hereof or the validity, enforceability
or legality of such offending term or provision in any other situation or jurisdiction or as applied to any person. 

Section 11. Successors 
 The terms of this Amendment shall be binding upon, and shall inure to the benefit of, the parties hereto and their respective successors and assigns. 

Section 12. Waiver of Jury Trial 
 EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES TRIAL BY
JURY IN ANY ACTION OR PROCEEDING WITH RESPECT TO THIS AMENDMENT OR
ANY OTHER LOAN DOCUMENT. 
 [SIGNATURE PAGES FOLLOW] 

  
 -5-

 IN WITNESS WHEREOF, the
parties hereto have caused this Amendment to be executed by their respective officers and general partners thereunto duly authorized, as of the date first written above. 

 

			
	 AMERICAN RENAL HOLDINGS
     INTERMEDIATE COMPANY, LLC

		
	    By: 	 	/s/ Steven M. Silver
		 	Name: Steven M. Silver
		 	Title: Authorized Person
	
	AMERICAN RENAL HOLDINGS INC.
		
	    By: 	 	/s/ Joseph A. Carlucci
		 	Name: Joseph A. Carlucci
		 	Title: CEO
	
	AMERICAN RENAL ASSOCIATES LLC
	
	    By: AMERICAN RENAL HOLDINGS INC.
		
	    By: 	 	/s/ Joseph A. Carlucci
		 	Name: Joseph A. Carlucci
		 	Title: CEO

  
 [American
Renal Credit Agreement Amendment No. 2 Signature Page] 

 By its signature below, each of the following Guarantors acknowledges and agrees that,
notwithstanding the execution and delivery of the foregoing Amendment, the Security Agreement and the Guaranty remain in full force and effect. 
  

			
	 AMERICAN RENAL MANAGEMENT LLC
 AMERICAN RENAL PRACTICE
 MANAGEMENT, LLC
 AKC HOLDING LLC
 JKC HOLDING LLC
 ARA-BOCA RATON HOLDING LLC
 ARA-OHIO HOLDINGS LLC

ARA-RHODE ISLAND DIALYSIS II LLC TEXAS-ARA LLC

ACUTE DIALYSIS SERVICES-ARA LLC

	
	    By: AMERICAN RENAL ASSOCIATES LLC
		
	    By: 	 	/s/ Joseph A. Carlucci
		 	Name: Joseph A. Carlucci
		 	Title: CEO
	
	 AMERICAN RENAL TEXAS L.P.
 AMERICAN RENAL TEXAS II, L.P.

	
	    By: TEXAS-ARA LLC
		
	    By: 	 	/s/ Joseph A. Carlucci
		 	Name: Joseph A. Carlucci
		 	Title: CEO

  
 [American
Renal Credit Agreement Amendment No. 2 Signature Page] 

			
	23-Aug-2012 12:04 PM Bank of America 980-683-6339	  	1/1

  

			
	 BANK OF AMERICA, N.A.,
     as Administrative Agent and as a Lender

		
	By: 	 	/s/ James B. Meanor
		 	Name : James B. Meanor
		 	Title: Director

  
 [American
Renal Credit Agreement Amendment No. 2 Signature Page] 

 
			
	BARCLAYS BANK PLC, as a Lender
		
	By: 	 	/s/ Lisa Minigh
		 	Name: Lisa Minigh
		 	Title: Assistant Vice President

  
 [American
Renal Credit Agreement Amendment No. 2 Signature Page] 

			
	WELLS FARGO BANK, NATIONAL     ASSOCIATION, as a Lender
		
	By: 	 	/s/ Caraline J. Vince
		 	Name: Caraline J. Vince
		 	Title: Assistant Vice President

  
 [American
Renal Credit Agreement Amendment No. 2 Signature Page] 

 SCHEDULE A 
 Schedule 2.01 
 Commitments and Applicable Percentages 

 

									
	 Lender
	  	Commitment	 	  	Applicable Percentage	 
	 Bank of America, N.A.
	  	$	23,125,000.00	  	  	 	61.666666667%	  
	 Barclays Bank PLC
	  	$	10,625,000.00	  	  	 	28.333333333%	  
	 Wells Fargo Bank, National Association
	  	$	3,750,000.00	  	  	 	10.000000000%	  
	 Total
	  	$	37,500,000.00	  	  	 	100.000000000%	  

  
 S-1

 BANK OF AMERICA, N.A. 

One Bryant Park 
 New York, New York 10036 
 August 27, 2012 

American Renal Holdings Inc. 
 66 Cherry Hill
Drive 
 Beverly, MA 01915 

	Attention:	Michael R. Costa, Esq., MPH 

  

	Re:	American Renal Holdings Inc. Fee Letter  

Dear Mr. Costa: 
 Reference
is hereby made to that certain amendment, dated as of the date hereof (the “Amendment”), to that certain credit agreement dated as of May 7, 2010 (as amended through the date hereof and as the same may be further
amended, supplemented or otherwise modified from time to time, the “Credit Agreement”) among C.P. Atlas Intermediate Holdings, LLC, American Renal Holdings Inc., as borrower (the “Borrower”), the
institutions from time to time party thereto as lenders, Bank of America, N.A. (“Bank of America”), as the administrative agent, and the other agents and arrangers party thereto. Capitalized terms used in this letter but not
defined herein shall have the meanings assigned to such terms in the Credit Agreement. The Amendment provides, among other things, that Bank of America will provide $12.5 million in additional Commitments to the Borrower under the Credit Agreement
(the “Additional Commitments”). 
 As compensation for providing the Additional Commitments, Borrower
shall pay to Bank of America a non-refundable cash fee equal to 1.0% of the aggregate amount of the Additional Commitments on the effective date of the Amendment. The payment of the fee set forth in the previous sentence will be in addition to any
other costs payable pursuant to the definitive documentation for the Amendment and will not be subject to counterclaim or setoff for, or be otherwise affected by, any claim or dispute. 

This letter itself does not constitute a commitment to provide the Additional Commitments or any other financing. 

This letter shall be governed by, and construed in accordance with, the laws of the State of New York. 

			
	23-Aug-2012 05:51 PM Bank of America 980-683-6343	  	1/1

 If this letter agreement reflects our agreement, please indicate your acceptance by signing in the space
below. 
  

			
	Sincerely,
	
	BANK OF AMERICA, N.A.
		
	By:	 	/s/ James B. Meanor
		 	 Name: James B. Meanor

		 	Title : Director

  

			
	 Acknowledged and Agreed as of
     the date first above written:

	
	AMERICAN RENAL HOLDINGS INC.
		
	By:	 	/s/ Joseph A.Carlucci
		 	 Name: Joseph A.Carlucci

Title: CEO

 IN WITNESS WHEREOF, the
parties hereto have caused this Amendment to be executed by their respective officers and general partners thereunto duly authorized, as of the date first written above. 

 

			
	AMERICAN RENAL HOLDINGS
    INTERMEDIATE COMPANY, LLC
		
	    By: 	 	/s/ Steven M. Silver
		 	 Name: Steven M. Silver

Title: Authorized Person

  

			
	AMERICAN RENAL HOLDINGS INC.
		
	    By: 	 	 
		 	Name:
		 	Title:

  

			
	AMERICAN RENAL ASSOCIATES
LLC1

  

			
	    By: AMERICAN RENAL HOLDINGS INC.
		
	    By: 	 	 
		 	Name:
		 	Title:

  

	1 	 American Renal to confirm guarantors. 

  
 [American
Renal Credit Agreement Amendment No. 2 Signature Page] 

 IN WITNESS WHEREOF, the undersigned has executed this unanimous written consent as of the
date first written above. 
  

			
	AMERICAN RENAL HOLDINGS, INC.
		
	By:	 	 
		 	 Name: Joseph A. Carlucci

Title: Chairman/Director

  

			
	By:	 	 
		 	 Name: Syed T. Kamal
 Title:
Director

  

			
	By:	 	 
		 	 Name: John J. McDonough

Title: Director

  

			
	By:	 	/s/ Steven M. Silver
		 	 Name: Steven M. Silver

Title: Director

  

			
	By:	 	/s/ Jared S. Hendricks
		 	 Name: Jared S. Hendricks

Title: Director

  

			
	By:	 	 
		 	 Name: Michael E. Boxer

Title: Director

  

			
	By:	 	 
		 	 Name: Thomas Erickson

Title: Director

  
 Page 3 of 3Waiver of Accelerated Vesting between Thomas Joyce and Knight Capital Group, Inc

 EXHIBIT 10.1 
 August 16, 2012 
 Knight Capital Group, Inc. 
 545 Washington Boulevard 
 Jersey City, NJ 07310 
 Dear Mesdames/Sirs: 
 Reference is made to the transactions contemplated by that certain Security
Purchase Agreement by and among Knight Capital Group, Inc. (the “Company”) and each of the investor signatories thereto, dated as of August 6, 2012 (the “Purchase Agreement”). This letter sets forth my agreement to waive any
change in control provisions in my employment agreement with the Company dated as of March 31, 2009 and the accelerated vesting provisions, if any, that may be triggered by any Change in Control (as that term is defined in the Equity Plans (as
defined below) or my employment agreement) that may be deemed to arise in connection with the initial investments contemplated by the Purchase Agreement and/or any conversion of non-voting securities of the Company acquired in such investment into
voting securities of the Company. This waiver is for all purposes of any awards in respect of Company common stock granted to me under the Company’s 2006 Equity Incentive Plan, Amended and Restated 2003 Equity Incentive Plan and 1998 Long-Term
Incentive Plan (collectively, the “Equity Plans”) that are unvested and outstanding as of the date hereof, as well as for purposes of the above referenced employment agreement (the “Waiver”). 

This letter does not affect any other terms of such plans, any awards under such plans (which shall continue to vest in accordance with their
current vesting schedule) or in any way waive any rights that I may have under any other compensatory or employment terms between me and the Company, and the Waiver is limited to any Change in Control that may be deemed to occur in connection with
the initial investments contemplated by the Purchase Agreement and/or any conversion of non-voting securities into voting securities of the Company. 
 Very truly yours, 
  

			
	By:	 	/s/ Thomas Joyce
	Name:	 	Thomas Joyce
	Title:	 	CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}]]